The fund said that international cooperation is a key condition for the successful fight against the COVID-19 pandemic.

“RDIF actively interacts with Samruk-Kazyna (National Welfare Fund of the Republic of Kazakhstan. - RT ) to supply advanced Russian solutions to the fight against coronavirus in Kazakhstan. 9.5 thousand packages of Avifavir have already arrived in Kazakhstan, the TASS statement quotes.

On May 30, an anti-COVID-19 drug called Avifavir received approval from the Ministry of Health.

The RDIF stated that the drug will be free in Russia as part of the compulsory medical insurance.